No, albumin should be discontinued in this postoperative lung transplant patient
In this critically ill postoperative patient, albumin administration should not be continued for volume replacement or to correct the low serum albumin level of 2.9 g/dL. The 2024 International Collaboration for Transfusion Medicine Guidelines explicitly recommend against using albumin for first-line volume replacement or to increase serum albumin levels in critically ill adults 1.
Rationale Against Continued Albumin Use
Guideline-Based Recommendations
The most recent high-quality evidence provides a conditional recommendation with moderate certainty that albumin should not be used in critically ill patients for:
- Volume replacement
- Correcting hypoalbuminemia alone 1
This recommendation applies directly to your patient's scenario—a postoperative critically ill patient with hypoalbuminemia (2.9 g/dL) and negative fluid balance.
Why Albumin Is Not Indicated Here
Postoperative hypoalbuminemia is expected and does not require correction: The guidelines specifically note that serum albumin decreases by 10-15 g/L postoperatively due to inflammatory cytokine suppression of synthesis and transcapillary loss 1. This is a physiologic response, not a therapeutic target.
No mortality or morbidity benefit: Multiple systematic reviews demonstrate that albumin does not improve patient outcomes in critically ill populations when used for volume replacement or hypoalbuminemia correction 1.
Potential harms outweigh benefits:
- Fluid overload (particularly concerning in lung transplant patients)
- Hypotension
- Hemodilution requiring RBC transfusion
- Anaphylaxis 1
Alternative Management Strategy
For Volume Replacement
Use crystalloid solutions as first-line therapy for the negative fluid balance. The patient's net-negative status of -780 mL/24h with high chest tube output requires volume replacement, but this should be accomplished with crystalloids 1.
For the Low Albumin Level
Do not treat the number. The albumin level of 2.9 g/dL in this postoperative context represents:
- Normal inflammatory response to major surgery
- Transcapillary albumin loss
- Suppressed hepatic synthesis 1
The FDA labeling acknowledges that "in hypoproteinemic states associated with...undernutrition, the infusion of albumin as a source of protein nutrition is not justified" 2.
For High Chest Tube Output
Focus on:
- Identifying and addressing the underlying cause of drainage
- Ensuring adequate crystalloid replacement
- Monitoring hemodynamic parameters
- Assessing for surgical complications
Important Caveats
The only FDA-approved postoperative indication for albumin in cardiac/thoracic surgery is during cardiopulmonary bypass priming—not for postoperative management 2. While one animal study suggested albumin in CPB priming might reduce endothelial dysfunction 3, a 2025 human study found albumin during lung transplantation did not independently reduce primary graft dysfunction 4.
Cost considerations: At approximately $130 per 25g, albumin represents significant expense without demonstrated benefit in this clinical scenario 1.
Monitor for complications: Given the patient is POD 13 after bilateral lung transplant and CABG, focus surveillance on: